Cost-Effectiveness of Empagliflozin in Chinese Patients with Type 2 Diabetes and Established Cardiovascular Disease- A Discrete Event Simulation Economic Modelling Study
May 1, 2018, 00:00
10.1016/j.jval.2018.04.497
https://www.valueinhealthjournal.com/article/S1098-3015(18)30797-6/fulltext
Title :
Cost-Effectiveness of Empagliflozin in Chinese Patients with Type 2 Diabetes and Established Cardiovascular Disease- A Discrete Event Simulation Economic Modelling Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30797-6&doi=10.1016/j.jval.2018.04.497
First page :
Section Title :
Open access? :
No
Section Order :
1306